In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...